3SBio submits software for Phase I medical trial of NuPIAO to the Chinese SFDA 3SBio Inc.

3SBio submits software for Phase I medical trial of NuPIAO to the Chinese SFDA 3SBio Inc. , a respected biotechnology company centered on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it provides submitted its program for a Phase I medical trial for NuPIAO to the Chinese Condition Food and Drug Administration http://www.edmdrx.com/ . NuPIAO is definitely a highly glycosylated ESA with extended half-existence and elevated biologic activity. Pre-clinical outcomes showed a promising pharmacokinetic profile which allows a once every week injection timetable of NuPIAO in human beings.

Ruttledge, Commissioner, Rehabilitation Services Administration, U.S. Division of Education; and Susan Gordon Ryan, Disability Rights Activist and Advocate. During a reception following the summit, United Spinal will honor Charles D. Hammerman, President & CEO, The Disability Chance Fund; Angela Melledy, Founder & Publisher, Capable Newspaper; and PepsiCo EnAble with this year’s 2010 Visionary Award, for their leadership, extraordinary service, and outstanding dedication to advancing the entire lives of people with disabilities.. 3rd Annual Disability Leadership and Policy Summit to commemorate 20th Anniversary of the ADA United Spinal Association will host the 3rd Annual Disability Leadership and Policy Summit commemorating the 20th Anniversary of the Americans with Disabilities Act on June 2nd in Hofstra University in Hempstead, New York.